Zobrazeno 1 - 10 of 179 pro vyhledávání: '"Em, Green"'
1
Early Development of Postural Control
Autor: Em Green, Cm Mulcahy, Te Pountney
Publikováno v: Physiotherapy. 77:187
Summary An investigation into the early postural development of normal infants has identified a sequence of lying abilities and a direct link between lying and sitting abilities.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::829ddf19d3e94f5485baf58d281873f3
https://doi.org/10.1016/s0031-9406(10)61701-4
Zobrazit plný text záznamu
3
Akademický článek
Small molecule inhibition of glycogen synthase I reduces muscle glycogen content and improves biomarkers in a mouse model of Pompe disease.
Autor: Gaspar RC; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States., Sakuma I; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States., Nasiri A; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States., Hubbard BT; Department of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, Connecticut, United States., LaMoia TE; Department of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, Connecticut, United States., Leitner BP; Department of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, Connecticut, United States., Tep S; Maze Therapeutics, South San Francisco, California,United States., Xi Y; Maze Therapeutics, South San Francisco, California,United States., Green EM; Maze Therapeutics, South San Francisco, California,United States., Ullman JC; Maze Therapeutics, South San Francisco, California,United States., Petersen KF; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States., Shulman GI; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States.; Department of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, Connecticut, United States.; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States.
Publikováno v: American journal of physiology. Endocrinology and metabolism [Am J Physiol Endocrinol Metab] 2024 Oct 01; Vol. 327 (4), pp. E524-E532. Date of Electronic Publication: 2024 Aug 22.
Zobrazit plný text záznamu
4
Akademický článek
First-in-Human Evaluation of Safety, Pharmacokinetics and Muscle Glycogen Lowering of a Novel Glycogen Synthase 1 Inhibitor for the Treatment of Pompe Disease.
Autor: Ullman JC; Maze Therapeutics, South San Francisco, California, USA., Dick RA; Maze Therapeutics, South San Francisco, California, USA., Linzner D; Maze Therapeutics, South San Francisco, California, USA., Minga T; Maze Therapeutics, South San Francisco, California, USA., Tep S; Maze Therapeutics, South San Francisco, California, USA., Satterfield TF; Maze Therapeutics, South San Francisco, California, USA., Xi Y; Maze Therapeutics, South San Francisco, California, USA., Beattie DT; Maze Therapeutics, South San Francisco, California, USA., Marmon T; Marmon Biostats, Fair Oaks, California, USA., Neutel JM; Orange County Research Center, Tustin, California, USA., Chung B; Maze Therapeutics, South San Francisco, California, USA., Leeds JM; Maze Therapeutics, South San Francisco, California, USA., Noonberg SB; Maze Therapeutics, South San Francisco, California, USA., Green EM; Maze Therapeutics, South San Francisco, California, USA., Bernstein HS; Maze Therapeutics, South San Francisco, California, USA.
Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Dec; Vol. 116 (6), pp. 1580-1592. Date of Electronic Publication: 2024 Oct 22.
Zobrazit plný text záznamu
5
Akademický článek
Clinical Education Data Management: Current Landscape in Entry-Level Physical Therapist Education.
Autor: Green EM; Dep. of Physical Therapy, California State University, Sacramento, 6000 J Street, MS 6020, Sacramento, CA 95819, USA. Tel 916-802-2778. erin.green@csus.edu., Wilkinson T, Howman J, Bayliss J, Perry L
Publikováno v: Journal of allied health [J Allied Health] 2024 Summer; Vol. 53 (2), pp. e77-e91.
Zobrazit plný text záznamu
6
Akademický článek
Defining Biological and Biochemical Functions of Noncanonical SET Domain Proteins.
Autor: Sun W; Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250, United States., Justice I; Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250, United States., Green EM; Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250, United States; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, United States. Electronic address: egreen@umbc.edu.
Publikováno v: Journal of molecular biology [J Mol Biol] 2024 Apr 01; Vol. 436 (7), pp. 168318. Date of Electronic Publication: 2023 Oct 19.
Zobrazit plný text záznamu
7
Akademický článek
Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders.
Autor: Ullman JC; Maze Therapeutics, South San Francisco, CA 94080, USA., Mellem KT; Maze Therapeutics, South San Francisco, CA 94080, USA., Xi Y; Maze Therapeutics, South San Francisco, CA 94080, USA., Ramanan V; Maze Therapeutics, South San Francisco, CA 94080, USA., Merritt H; Maze Therapeutics, South San Francisco, CA 94080, USA., Choy R; Maze Therapeutics, South San Francisco, CA 94080, USA., Gujral T; Maze Therapeutics, South San Francisco, CA 94080, USA., Young LEA; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40506, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA., Blake K; Maze Therapeutics, South San Francisco, CA 94080, USA., Tep S; Maze Therapeutics, South San Francisco, CA 94080, USA., Homburger JR; Maze Therapeutics, South San Francisco, CA 94080, USA., O'Regan A; Maze Therapeutics, South San Francisco, CA 94080, USA., Ganesh S; Maze Therapeutics, South San Francisco, CA 94080, USA., Wong P; Maze Therapeutics, South San Francisco, CA 94080, USA., Satterfield TF; Maze Therapeutics, South San Francisco, CA 94080, USA., Lin B; Maze Therapeutics, South San Francisco, CA 94080, USA., Situ E; Maze Therapeutics, South San Francisco, CA 94080, USA., Yu C; Maze Therapeutics, South San Francisco, CA 94080, USA., Espanol B; Maze Therapeutics, South San Francisco, CA 94080, USA., Sarwaikar R; Maze Therapeutics, South San Francisco, CA 94080, USA., Fastman N; Maze Therapeutics, South San Francisco, CA 94080, USA., Tzitzilonis C; Maze Therapeutics, South San Francisco, CA 94080, USA., Lee P; Maze Therapeutics, South San Francisco, CA 94080, USA., Reiton D; Maze Therapeutics, South San Francisco, CA 94080, USA., Morton V; Maze Therapeutics, South San Francisco, CA 94080, USA., Santiago P; Maze Therapeutics, South San Francisco, CA 94080, USA., Won W; Maze Therapeutics, South San Francisco, CA 94080, USA., Powers H; Maze Therapeutics, South San Francisco, CA 94080, USA., Cummings BB; Maze Therapeutics, South San Francisco, CA 94080, USA., Hoek M; Maze Therapeutics, South San Francisco, CA 94080, USA., Graham RR; Maze Therapeutics, South San Francisco, CA 94080, USA., Chandriani SJ; Maze Therapeutics, South San Francisco, CA 94080, USA., Bainer R; Maze Therapeutics, South San Francisco, CA 94080, USA., DePaoli-Roach AA; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Roach PJ; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Hurley TD; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Sun RC; Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL 32610, USA.; USA Center for Advanced Spatial Biomolecule Research, University of Florida, Gainesville, FL 32610, USA., Gentry MS; Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL 32610, USA., Sinz C; Maze Therapeutics, South San Francisco, CA 94080, USA., Dick RA; Maze Therapeutics, South San Francisco, CA 94080, USA., Noonberg SB; Maze Therapeutics, South San Francisco, CA 94080, USA., Beattie DT; Maze Therapeutics, South San Francisco, CA 94080, USA., Morgans DJ Jr; Maze Therapeutics, South San Francisco, CA 94080, USA., Green EM; Maze Therapeutics, South San Francisco, CA 94080, USA.
Publikováno v: Science translational medicine [Sci Transl Med] 2024 Jan 17; Vol. 16 (730), pp. eadf1691. Date of Electronic Publication: 2024 Jan 17.
Zobrazit plný text záznamu
8
Report
Severe polycystic liver disease in a cat.
Autor: King EM; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA., Pappano M; Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA., Lorbach SK; Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA., Green EM; Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA., Parker VJ; Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA., Schreeg ME; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA.
Publikováno v: JFMS open reports [JFMS Open Rep] 2023 Dec 24; Vol. 9 (2), pp. 20551169231216859. Date of Electronic Publication: 2023 Dec 24 (Print Publication: 2023).
Zobrazit plný text záznamu
9
Akademický článek
The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer.
Autor: Ikram S; Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD, USA., Rege A; Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD, USA., Negesse MY; Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD, USA., Casanova AG; Grenoble Alpes University, CNRS UMR5309, INSERM U1209, Institute for Advanced Biosciences, Grenoble, France., Reynoird N; Grenoble Alpes University, CNRS UMR5309, INSERM U1209, Institute for Advanced Biosciences, Grenoble, France., Green EM; Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD, USA.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.
Publikováno v: Science advances [Sci Adv] 2023 Nov 15; Vol. 9 (46), pp. eadi5921. Date of Electronic Publication: 2023 Nov 17.
Zobrazit plný text záznamu
10
Akademický článek
Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
Autor: Hung AM; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Assimon VA; Maze Therapeutics, South San Francisco, California., Chen HC; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Yu Z; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Vlasschaert C; Department of Medicine, Queen's University, Kingston, Ontario, Canada., Triozzi JL; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Chan H; Maze Therapeutics, South San Francisco, California., Wheless L; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee., Wilson O; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Shah SC; VA San Diego Healthcare System and UC San Diego Health, La Jolla, California., Mack T; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.; Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Thompson T; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Matheny ME; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee., Chandrasekar S; Maze Therapeutics, South San Francisco, California., Mozaffari SV; Maze Therapeutics, South San Francisco, California., Chung CP; Department of Rheumatology, Vanderbilt University Medical Center, Nashville, Tennessee., Tsao P; VA Palo Alto Health Care System, Palo Alto, California.; Department of Medicine, Stanford University School of Medicine, Stanford, California., Susztak K; Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania., Siew ED; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Estrada K; Maze Therapeutics, South San Francisco, California., Gaziano JM; VA Cooperative Studies Program, VA Boston Healthcare System, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard School of Medicine, Boston, Massachusetts., Graham RR; Maze Therapeutics, South San Francisco, California., Tao R; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Hoek M; Maze Therapeutics, South San Francisco, California., Robinson-Cohen C; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Green EM; Maze Therapeutics, South San Francisco, California., Bick AG; Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; VA Cooperative Studies Program, VA Boston Healthcare System, Boston, Massachusetts.
Publikováno v: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2023 Nov 01; Vol. 34 (11), pp. 1889-1899. Date of Electronic Publication: 2023 Oct 06.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje